Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Palliative Management of Advanced Hepatocellular Carcinoma
NCT01935700Phase 2Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Jun 2013
- Primary completion
- May 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in hepatocellular carcinoma (HCC), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Jun 2013; status: completed.
02
Drugs
colchicine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01935700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935700.